Results 111 to 120 of about 10,873 (203)

Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy. [PDF]

Adv Ther
Pompilio G, Bellomo C, Pio Mondello Malvestiti FM, Aspromonte N.   +3 more
europepmc   +1 more source

Cardiorenal Effects of Switching from Eplerenone to Esaxerenone in Patients with Chronic Heart Failure and Hypertension: A Prospective Clinical Study. [PDF]

J Pers Med
Sezai A, Abe M, Maruyama T, Taoka M, Sekino H, Tanaka M.   +5 more
europepmc   +1 more source

Initiation of eplerenone vs. spironolactone and all-cause mortality in HFrEF: linked database study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Svanström H, Hviid A, Pasternak B.
europepmc   +1 more source

Functional and Structural Outcomes of Photodynamic Therapy (PDT) With or Without Eplerenone for Central Serous Chorioretinopathy. [PDF]

J Clin Med
Gregori G, Centini C, Mangoni L, Muzi A, Fruttini D, Quarta A, Ruggeri ML, Rizzo C, Bongiovanni G, Mastropasqua R, Mariotti C, Lupidi M.   +11 more
europepmc   +1 more source

Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis. [PDF]

Front Med (Lausanne)
Lin HH, Cui WH, Xu F, He JY, Li LC, Xu JJ, Jiang X, Mao KL.   +7 more
europepmc   +1 more source

PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties. [PDF]

Clin Kidney J
Agarwal R, Vogt L, Floege J, Zoccali C.
europepmc   +1 more source

The impact of mineralocorticoid receptor antagonists on fat mass and fat metabolism. [PDF]

J Endocrinol Invest
Afsar B, Afsar RE, Maddukuri G.
europepmc   +1 more source

Late-gestation mineralocorticoid receptor antagonism lowers maternal blood pressure and attenuates placental insufficiency induced by leptin in pregnant mice. [PDF]

Am J Physiol Heart Circ Physiol
Sones JL.
europepmc   +1 more source

Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone. [PDF]

Open Heart
Szakál I, Komlósi F, Tóth P, Arnóth B, Bohus G, Vámosi P, Szegedi N, Salló Z, Osztheimer I, Perge P, Orbán G, Kardos A, Merkely B, Gellér L, Nagy KV.   +14 more
europepmc   +1 more source

Ultrawide-field indocyanine angiography changes post 12 weeks of eplerenone in central serous chorioretinopathy. [PDF]

Indian J Ophthalmol
Sagar A, Mishra S, Kumar P, Sati A, Gupta A, Avasthi A, Srujana D, Dhar S, Khaleel M, Joshi A.   +9 more
europepmc   +1 more source